Patent Assignment
Reel/Frame 030155/0822
Assignment of Assignor's Interest
Recorded: 2013-04-04
Pages: 39
Assignor
ELAN PHARMA INTERNATIONAL LIMITED
Executed: 2013-04-02
Assignee
BIOGEN IDEC INTERNATIONAL HOLDING LTD.
CANON'S COURT, 22 VICTORIA STREET, HAMILTON, HM EX, BERMUDA
Covered Properties
(96)
Blood-Brain Barrier Model
Application:
07/413,274 →
Blood-Brian Barrier Model
Patent:
5,260,210 →
Application:
07/577,650 →
Compositions and Methods for Modulating Leukocyte Adhesion to Brain Endothelial Cells
Application:
07/871,223 →
Humanized Antibodies Against Leukocyte Adhesion Molecule Vla-4
Application:
08/186,269 →
Compositions and Methods for Modulating Leukocyte Adhesion to Brain Endothelial Cells
Application:
08/402,962 →
Novel Integrin Blocking Molecule
Patent:
5,811,514 →
Application:
08/457,192 →
Inhibitors of Leukocyte Adhesion
Patent:
6,001,809 →
Application:
08/467,580 →
Treatment of Viral Encephalitis by Agents Blocking Alph-4INTEGRIN Function
Application:
09/010,377 →
Substituted Phenylalanine Type Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
6,492,421 →
Application:
09/126,095 →
Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
7,030,114 →
Application:
09/126,096 →
Dipeptide and Related Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
6,423,688 →
Application:
09/126,329 →
Dipeptide Compounds Useful as Vla-4 Receptor Antagonists
Application:
09/127,346 →
Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
6,559,127 →
Application:
09/127,533 →
Benzyl Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
6,362,341 →
Application:
09/127,601 →
The Use of Humanized Antibodies Against Alpha-4 Integrin in the Treatment of Rheumatoid Arthritis
Application:
09/155,739 →
Pyroglutamic Acid Derivatives and Related Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
6,407,066 →
Application:
09/489,164 →
Fused Ring Heteroaryl and Heterocyclic Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
6,545,003 →
Application:
09/489,271 →
Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
6,436,904 →
Application:
09/489,589 →
Alpha-Aminoacetic Acid Derivatives - ALPHA4BETA7 Receptor Antagonists
Patent:
6,410,781 →
Application:
09/514,773 →
Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Patent:
6,583,139 →
Application:
09/688,820 →
Heteroaryl-Beta-Alanine Derivatives as Alpha 4 Integrin Inhibitors
3-(Heteroaryl) Alanine Derivatives-Inhibitors of Leukocyte Adhesion Mediated by Vla-4
Phenylalanine Derivatives as Alpha 4 Integrin Inhibitors
Alpha Amino Acid Derivatives--Inhibitors of Leukocyte Adhesion Mediated by Vla-4
Benzyl Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Dipeptide and Related Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Pyroglutamic Acid Derivatives and Related Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Alpha-Aminoacetic Acid Derivatives- ALPHA4BETA7 Receptor Antagonists
Fused Ring Heteroaryl and Heterocyclic Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Carbamyloxy Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Administration of agents for the treatment of inflammation
Application:
10/372,111 →
Publication:
US 2004/0009169
Compounds which inhibit leukocyte adhesion mediated by VLA-4
Application:
10/382,988 →
Publication:
US 2004/0006093
Heteroaryl Compounds Which Inhibit Leukocyte Adhesion Mediated by ALPHA4 Integrins
Heteroaryl Compounds Which Inhibit Leukocyte Adhesion Mediated by Alpha-4 Integrins
Phenylalanine Derivatives as Alpha 4 Integrin Inhibitors
Heteroaryl, Heterocyclic and Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
Application:
10/763,424 →
Publication:
US 2005/0069541
Immunoglobulin formulation and method of preparation thereof
Application:
10/773,406 →
Publication:
US 2005/0053598
Methods and compositions for treating rheumatoid arthritis
Application:
10/875,469 →
Publication:
US 2005/0074451
3-(Heteroaryl) Alanine Derivatives-Inhibitors of Leukocyte Adhesion Mediated by Vla-4
Treatment of viral encephalitis by agents blocking alpha-VLA-4 integrin function
Application:
11/016,386 →
Publication:
US 2006/0029600
Steroid sparing agents and methods of using same
Application:
11/095,822 →
Publication:
US 2006/0004019
Beta-Amino Acid Derivatives-Inhibitors of Leukocyte Adhesion Mediated by Vla-4
Anti-inflammatory compositions and methods
Application:
11/147,601 →
Publication:
US 2005/0272668
Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
Application:
11/285,889 →
Publication:
US 2006/0074110
3-(Heteroaryl)Alanine Derivatives-Inhibitors of Leukocyte Adhesion Mediated by Vla-4
Application:
11/873,358 →
Publication:
US 2008/0182850
Lyophilized Immunoglobulin Formulations and Methods of Preparation
Application:
12/138,075 →
Publication:
US 2009/0208492
Carbamyl Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/054,453 →
Dipeptide and Related Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/100,429 →
Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/108,164 →
Benzyl Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/112,007 →
Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/112,010 →
4-Amino-Phenylalanine Type Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/112,019 →
Carbamyl Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/112,020 →
Multicyclic Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/116,735 →
Heteroaryl Heterocyclic and Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/116,923 →
Fused Ring Heteroaryl and Heterocyclic Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/116,967 →
Fused Ring Heteroaryl and Heterocyclic Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/117,742 →
Multicyclic Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/117,743 →
Alpha -Aminoacetic Acid Derivatives-ALPHA4B7 Receptor Antagonists
Application:
60/122,071 →
Heteroaryl, Heterocyclic and Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated by Vla-4
Application:
60/160,999 →
Cat boots
Application:
60/183,005 →
Beta-amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4
Application:
60/220,118 →
Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
Application:
60/220,128 →
3-(Heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
Application:
60/220,131 →
Alpha amino acid derivatives inhibitors of leukocyte adhesion mediated by VLA-4
Application:
60/220,132 →
Phenylalanine derivatives as alpha 4 integrin inhibitors
Application:
60/220,134 →
Administration of agents for the treatment of inflammation
Application:
60/360,134 →
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
Application:
60/383,020 →
Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
Application:
60/383,244 →
Reversal of inflammatory response by inhibition of alpha-4 integrin to inhibit demyelination
Application:
60/442,171 →
Immunoglobulin formulation and method of preparation thereof
Application:
60/445,818 →
Methods and compositions for treating rheumatoid arthritis
Application:
60/482,211 →
Reversal of inflammatory response by inhibition of alpha-4 integrin to inhibit demyelination and reverse paralysis
Application:
60/500,316 →
Polyethylene glycol conjugates of dipeptides
Application:
60/538,573 →
Methods and compositions for treating tumors and metastatic disease
Application:
60/541,946 →
Steroid sparing agents and methods of using same
Application:
60/558,120 →
Steroid sparing agents and methods of using same
Application:
60/558,121 →
Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4
Application:
60/566,784 →
Multimeric VLA-4 antagonists comprising polymer moieties
Application:
60/586,975 →
Imidazolone phenylalanine derivatives
Application:
60/683,509 →
Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds
Application:
60/697,726 →
Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
Application:
60/722,355 →
Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
Application:
60/722,358 →
Methods of treating inflammatory and autoimmune disease with natalizumab
Application:
60/776,931 →
Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4
Application:
60/777,595 →
Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
Application:
60/777,797 →
Methods of treating inflammatory and autoimmune diseases with natalizumab
Application:
60/779,190 →
Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds
Application:
60/802,349 →
Methods and compositions for treating liquid tumors
Application:
60/996,846 →
Pyridinone Antagonists of Alpha-4 Integrins
Application:
61/172,876 →
Selective Integrin Inhibitors
Application:
61/330,122 →
Selective Integrin Inhibitors
Application:
61/392,288 →
Methods for Determining Differences in Alpha-4 Integrin Activity by Correlating Differences in sMadCAM Levels
Application:
61/406,358 →
Methods for Determining Differences in Alpha-4 Integrin Activity by Correlating Differences in sVCAM Levels
Application:
61/406,365 →
Selective integrin inhibitors
Application:
61/516,845 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2013
From: ELAN PHARMACEUTICALS, INC.
To: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Reel/Frame 031214/0424 →
Assignment of Assignor's Interest
Sep 16, 2013
From: BIOGEN IDEC INTERNATIONAL HOLDING LTD.
To: BIOGEN IDEC MA INC.
Reel/Frame 031214/0500 →
Assignment of Assignor's Interest
Jan 15, 2014
From: BENDIG, MARY M.; LEGER, OLIVIER J.; SALDANHA, JOSE; JONES, S. TARRAN
To: ATHENA NEUROSCIENCES, INC.; MRC COLLABORATIVE CENTRE
Reel/Frame 031978/0211 →
Assignment of Assignor's Interest
Jan 15, 2014
From: YEDNOCK, TED A.
To: ATHENA NEUROSCIENCES, INC.
Reel/Frame 031978/0325 →
Assignment of Assignor's Interest
Jan 15, 2014
From: MRC COLLABORATIVE CENTRE
To: ATHENA NEUROSCIENCES, INC.
Reel/Frame 031978/0345 →